Author

Beatriz Castelo

Hospital Universitario La PazORCID 0000-0002-4759-5035Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Ana Belén Griso-AcevedoiD· 1 shared Ana Sastre-PeronaiD· 1 shared Francisco NavasiD· 1 shared Javier GonzaleziD· 1 shared José Luis Cebrián-CarreteroiD· 1 shared María José Morán SotoiD· 1 shared Natalia L. CalvoiD· 1 shared Rafael A. García‐MuñoziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Belén Griso-AcevedoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Overcoming Cisplatin Resistance in 3D Oral Squamous Cell Carcinoma Models via Nanoparticle-Mediated Pt(IV) Drug Delivery.

Ana Belén Griso-Acevedo, Francisco Navas, Natalia L. Calvo, Victoria Morales, Beatriz Castelo, Javier Gonzalez, María José Morán Soto, Raúl Sanz, José Luis Cebrián-Carretero, Rafael A. García‐Muñoz, Ana Sastre-Perona

This study evaluates Pt(IV)-based prodrug delivery via mesoporous silica nanoparticles in 3D oral squamous cell carcinoma models, showing improved cytotoxicity and apoptotic effects compared to cisplatin.

bioRxiv · Feb 23, 2026 · PreprintCancer Biology